Acucela Inc logo
VerifiedBiotechnology Research· Founded 2002

Acucela Inc

Acucela Inc. is a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co, Ltd.(Tokyo 4596), committed to translating innovation into a diverse portfolio of drugs and devices to preserve and restore vision for millions of people worldwide. Acucela’s development pipeline include drug candidates and therapeutics for the treatment of retinitis pigmentosa, proliferative diabetic retinopathy, diabetic macular edema, AMD, Stargardt disease, cataract and presbyopia. The company is also developing a monitoring device for neovascular retinal diseases, to be used directly by patients.

7-day free trial · no credit card

HeadquartersSeattle, United StatesEmployees25(11 to 50)Annual revenue$10M to <$50MFounded year2002Websitekubotavision.comLinkedIn profileLinkedIn

Verified contacts

22

available on Kipplo

LinkedIn employees

25

11 to 50 range

Open roles

no listings

Distinct roles

19

indexed titles

Tech stack

1

tools in use

Monthly traffic

35

organic / mo

Sign up free to see all 22 verified contacts at Acucela Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

22 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Acucela Inc

19 distinct titles indexed · top 10 shown.

  • 2corporate communications
  • 1acuariofilia
  • 1clinical research associate
  • 1clinical trial manager
  • 1communications coordinator
  • 1contracts paralegal
  • 1coo
  • 1cra
  • 1engineer
  • 1front desk receptionist
  • +9more titles

Sign up to unlock all 22 contacts at Acucela Inc

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 22 verified contacts at Acucela Inc

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Acucela Inc | Kipplo Discover